Literature DB >> 23279657

The gastrointestinal manifestations of telomere-mediated disease.

Naudia L Jonassaint1, Nini Guo, Joseph A Califano, Elizabeth A Montgomery, Mary Armanios.   

Abstract

Defects in telomere maintenance genes cause pathological telomere shortening, and manifest in syndromes which have prominent phenotypes in tissues of high turnover: the skin and bone marrow. Because the gastrointestinal (GI) epithelium is highly proliferative, we sought to determine whether telomere syndromes cause GI disease, and to define its prevalence, spectrum, and natural history. We queried subjects in the Johns Hopkins Telomere Syndrome Registry for evidence of luminal GI disease. In sixteen percent of Registry subjects (6 of 38), there was a history of significant GI pathology, and 43 additional cases were identified in the literature. Esophageal stenosis, enteropathy, and enterocolitis were the recurrent findings. In the intestinal mucosa, there was striking villous atrophy, extensive apoptosis, and anaphase bridging pointing to regenerative defects in the epithelial compartment. GI disease was often the first and most severe manifestation of telomere disease in young children. These findings indicate that telomere dysfunction disrupts the epithelial integrity in the human GI tract manifesting in recognizable disease processes. A high index of suspicion should facilitate diagnosis and management.
© 2012 The Authors Aging Cell © 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2013        PMID: 23279657      PMCID: PMC3602337          DOI: 10.1111/acel.12041

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  44 in total

Review 1.  Dyskeratosis congenita.

Authors:  A Marrone; P J Mason
Journal:  Cell Mol Life Sci       Date:  2003-03       Impact factor: 9.261

Review 2.  Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum--a single-center pediatric experience.

Authors:  S Jyonouchi; L Forbes; E Ruchelli; K E Sullivan
Journal:  Pediatr Allergy Immunol       Date:  2011-02-01       Impact factor: 6.377

3.  Dyskeratosis congenita: report of two cases with distinct clinical presentations.

Authors:  Fatma Elif Demirgüneş; Gonca Elçin; Sedef Sahin
Journal:  Turk J Pediatr       Date:  2008 Nov-Dec       Impact factor: 0.552

4.  Severe variant of x-linked dyskeratosis congenita (Hoyeraal-Hreidarsson Syndrome) causes significant enterocolitis in early infancy.

Authors:  Ingo Borggraefe; Sibylle Koletzko; Tina Arenz; Monika Fuehrer; Florian Hoffmann; Inderjeet Dokal; Tom Vulliamy; Véronique Weiler; Matthias Griese; Bernd H Belohradsky; Thomas Lang
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-09       Impact factor: 2.839

5.  Treatment of neutropenia associated with dyskeratosis congenita with granulocyte-macrophage colony-stimulating factor.

Authors:  C L Russo; B E Glader; R J Israel; F Galasso
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

6.  Dyskeratosis congenita: oral hyperkeratosis in association with lichenoid reaction.

Authors:  T P B Handley; G R Ogden
Journal:  J Oral Pathol Med       Date:  2006-09       Impact factor: 4.253

7.  Longevity, stress response, and cancer in aging telomerase-deficient mice.

Authors:  K L Rudolph; S Chang; H W Lee; M Blasco; G J Gottlieb; C Greider; R A DePinho
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

8.  Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantation.

Authors:  A Ghavamzadeh; K Alimoghadam; P Nasseri; M Jahani; A Khodabandeh; G Ghahremani
Journal:  Bone Marrow Transplant       Date:  1999-02       Impact factor: 5.483

9.  Atypical dyskeratosis congenita.

Authors:  S S Krishnan; P D Yesudian; M Jayaraman; V R Janaki; J B Raj
Journal:  Indian J Dermatol Venereol Leprol       Date:  1997 Jan-Feb       Impact factor: 2.545

Review 10.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

View more
  41 in total

1.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

Review 2.  Telomere dynamics in mice and humans.

Authors:  Rodrigo T Calado; Bogdan Dumitriu
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

3.  Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Authors:  Amany I Gorgy; Naudia L Jonassaint; Susan E Stanley; Ayman Koteish; Amy E DeZern; Jolan E Walter; Sabrina C Sopha; James P Hamilton; Julie Hoover-Fong; Allen R Chen; Robert A Anders; Ihab R Kamel; Mary Armanios
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

4.  Telomere dysfunction causes alveolar stem cell failure.

Authors:  Jonathan K Alder; Christina E Barkauskas; Nathachit Limjunyawong; Susan E Stanley; Frant Kembou; Rubin M Tuder; Brigid L M Hogan; Wayne Mitzner; Mary Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-03       Impact factor: 11.205

5.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

Review 6.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

7.  Telomeric epigenetic response mediated by Gadd45a regulates stem cell aging and lifespan.

Authors:  Daojun Diao; Hu Wang; Tangliang Li; Zhencan Shi; Xiaoqing Jin; Tobias Sperka; Xudong Zhu; Meimei Zhang; Fan Yang; Yusheng Cong; Li Shen; Qimin Zhan; Jing Yan; Zhangfa Song; Zhenyu Ju
Journal:  EMBO Rep       Date:  2018-08-20       Impact factor: 8.807

8.  Telomerase mutations in smokers with severe emphysema.

Authors:  Susan E Stanley; Julian J L Chen; Joshua D Podlevsky; Jonathan K Alder; Nadia N Hansel; Rasika A Mathias; Xiaodong Qi; Nicholas M Rafaels; Robert A Wise; Edwin K Silverman; Kathleen C Barnes; Mary Armanios
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

Review 9.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 10.  Bone marrow failure and the telomeropathies.

Authors:  Danielle M Townsley; Bogdan Dumitriu; Neal S Young
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.